App gallery
Build something with the Amass API
Small starter apps from the Amass team and community — fork, remix, and ship.
App gallery
Small starter apps from the Amass team and community — fork, remix, and ship.
Type a human gene → every drug built against it, from genetic constraint to FDA/EMA approval, across 5 Amass cores. Click any drug for trials, approvals, mechanism & papers.

Type a research topic; Amass trust-screens the literature, recovers studies your search missed via citation snowballing, flags retractions, and exports RIS/BibTeX/CSL.

Pick a contested football-health question — does heading the ball damage the brain? — and watch the top medical studies disagree in their own words. The app picks no side.

Type a disease and watch every late-stage clinical trial of the last 25 years settle as a field of dots — red where halted, green where still alive.

Type a drug and read every FDA and EMA expedited pathway it actually boarded — Breakthrough, Fast Track, Priority Review, Accelerated Approval — on one airport-style board.

Type one drug and watch its development program expand across Phase-3 indications over time — each dated by its first pivotal trial, with FDA & EMA approval milestones.

See the shape of a drug's clinical-trial evidence at a glance: real trials vs real-world studies, by phase, rigour, funder, and how much of it is actually published.

A world map of where a drug is being tested in clinical trials — and which countries are actively enrolling patients right now.
Type a drug and an emerging use a patient asked about, and see every registered trial as a maturity ladder — the not-yet-recruiting future trial pinned on top, verbatim.
Type one drug and see every FDA accelerated-approval promise — and whether the confirmatory trial has read out or the evidence is still pending — read verbatim from the registry.
Type one drug and see its FDA and EMA regulatory stories side by side — approved one side, refused or withdrawn the other — read verbatim from the registry.
Paste a manuscript's authors and your candidate peer reviewers; it flags recent co-authorship conflicts and any retractions, read from the public record and ORCID-disambiguated.
Type 2–5 drugs and see which registered trials tested them head-to-head vs co-administered them — read from each trial's verbatim wording, with trust-filtered evidence.

See a landmark clinical trial's evidence base accrete for a decade after it ended — every linked paper placed on a lag axis, ranked by journal trust tier and citation weight.
Enter a drug name for an asset due-diligence dossier on the Amass API: trial pipeline, trust-filtered evidence, retraction flags, and momentum trends.
Paste a bibliography — see which papers were retracted and how far the contamination cascade reaches in a single 3-direction fetch.

Weekly competitive-intelligence digest for biotech pipeline-watchers. Surfaces new Phase 2/3 trials per sponsor via per-sponsor TrialCore search.
A regulatory-review demo that compares a marketing claim against the cited trial's registered primary endpoint, surfacing a verbatim outcome and a flagged verdict.
Resolve PMIDs, DOIs, and NCT IDs to canonical Amass IDs in a single batch — with clean per-item errors and cross-walked alternate IDs attached for free.